Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases.
BACKGROUND
Malignant pleural effusion is a common sequelae in patients with certain malignancies. It represents a terminal condition with short median survival (in terms of months) and the goal is palliation. Aim of our study is to analyze morbidity, mortality and life expectancy following videothoracoscopic talc poudrage.


METHODS
From September 2004 to October 2009, 400 patients underwent video-assisted thoracic surgery (VATS) for malignant pleural effusion. The conditions of patients were assessed and graded before and after treatment concerning morbidity, mortality, success rate of pleurodesis and median survival.


RESULTS
The median duration of follow up was 40 months (range 4-61 months). All patients demonstrated notable improvement in dyspnea. Intraoperative mortality was zero. The procedure was well tolerated and no significant adverse effects were observed. In hospital mortality was 2% and the pleurodesis success rate was 85%. A poor Karnofsky Performance Status and delay between diagnosis of pleural effusion and pleurodesis were statistically significant factors for in-hospital mortality. The best survival was seen in breast cancer, followed by ovarian cancer, lymphoma and pleural mesothelioma.


CONCLUSIONS
Video-assisted thoracoscopic talc poudrage is an effective and safe procedure that yields a high rate of successful pleurodesis and achieves long-term control with marked dyspnea decrease.
Barbetakis
Nikolaos
N
Thoracic Surgery Department, Theagenio Cancer Hospital, A, Simeonidi 2, Thessaloniki, 54007, Greece. nibarbet@yahoo.gr
Asteriou
Christos
C
Papadopoulou
Fani
F
Samanidis
Georgios
G
Paliouras
Dimitrios
D
Kleontas
Athanassios
A
Lyriti
Konstantina
K
Katsikas
Ioannis
I
Tsilikas
Christodoulos
C
D006801:Humans; D010166:Palliative Care; D016066:Pleural Effusion, Malignant / Q000401:mortality / Q000628:therapy*; D018700:Pleurodesis / Q000009:adverse effects; D012008:Recurrence; D013627:Talc / Q000008:administration & dosage* / Q000009:adverse effects; D013906:Thoracoscopy; D014741:Video Recording
D013627:Talc
Am J Respir Crit Care Med. 2000 Nov;162(5):1987-2001
11069845
Curr Opin Pulm Med. 2009 Jul;15(4):380-7
19436206
West J Surg Obstet Gynecol. 1958 Jan-Feb;66(1):26-8
13507360
Ann Thorac Surg. 2002 Jul;74(1):213-7
12118761
Eur J Cardiothorac Surg. 2002 Feb;21(2):302-5; discussion 305-6
11825740
Ann Thorac Surg. 2001 Jun;71(6):1809-12
11426752
Acta Chir Hung. 1999;38(2):155-7
10596319
Chest. 1989 Feb;95(2):320-4
2914482
Ann Intern Med. 1988 Mar;108(3):345-9
3341671
Chest. 2005 Sep;128(3):1798-804
16162789
Chest. 2001 Jul;120(1):19-25
11451810
Chest. 2001 Mar;119(3):801-6
11243960
World J Surg Oncol. 2004 May 20;2:16
15153245
Ann Thorac Surg. 1996 Dec;62(6):1655-8
8957368
Chest. 1993 Apr;103(4 Suppl):385S-389S
7681744